Marc Beer has had an astounding career with more than 25 years in the Pharmaceutical industry. Over the years, Beer has bought success to several companies by using his unique strategy that gives immediate solutions and resolves any pressing matters in a workable environment. Because of his unique development success with other companies, Marc Beer decided to start his own company.
Beer’s recent success has to do with his title as a co-founder, CEO, and Chairman of Renovia. Beginning In 2016, Beer was joined by Dr. Iglesias and Yolanda Lorié to launch Renovia. Renovia is a Boston-based medical and technologically driven company that focuses on carefully constructing therapeutic devices as well as diagnostic devices for women who suffer from pelvic floor disorders. This new technology provides real-time diagnosis and treatment. When it comes to pelvic floor disorders this can mean that the pelvic organ has prolapsed, there is urinary incontinence, and there is fecal incontinence. This disorder affects about 25% of women in the United States. After pulling the data, the affected numbers that Beer saw among women allowed him to set in motion a plan. Those who suffer from pelvic floor disorders categorize it as a serious issue that brings physician costs alone to about $298 million. This statistic was reported from 2005 through 2006.
After launch, 2018 became the pinnacle year for Renovia. By this year the company had pushed out its first product known as Leva, and it was approved by the FDA in mid-April. Beer was able to obtain a Series B funding for Renovia in the amount of $32 million for products and another $10 million for venture funding. Series B funding is supported by Perceptive Advisors of New York and Missouri’s Ascension Ventures.
Success as a Chairman
Recently, Marc Beer holds the title of Chairman with the Board of LumeNXT. LumeNXT is a biomedical company that develops and distributes surgical products. Beer partnered with Paul Rhyne, who is the co-founder of LumeNXT and has mentioned that the success of the company is because of Beer’s 25 years of experience with successful bringing profit to startup pharmaceutical and medical companies. Beer is quoted as being optimistic in his leadership roles and that has been one of the contributing factors to the increasing profitability of LumeNXT for the next couple of years. His success rate when it comes to obtaining funding from several biomedical companies and turning them into investors, allowed Beer to be the best candidate to take the role of Chairman at LumeNXT.
After a few years, LumeNXT went public because of Beer’s vision and leadership work efforts. Another success company under Marc’s name is Minerva Neurosciences. Minerva has had a successful break-through with Beer serving as the chairman. He has helped the company become one of the leading developers for diagnostic and treatment with helping diseases that center around the central nervous system. Beer’s experience also landed him a position on the board of numerous pharmaceutical companies that successfully made headlines such as Erytech Pharma. Learn more: https://www.prnewswire.com/news-releases/lumenxt-names-marc-beer-chairman-of-the-board-300822547.html
In 1987, Marc Beer graduated with his BS from Miami University in Oxford, OH. He is also known for his roles as the Founding Chairman of the board of directors, chairman of the compensation committee for Good Start Genetics Incorporated, a member of the audit committee of Minerva Neurosciences, and a member of the MiamiU Business Advisory Council.